Bjorn Fischler
Overview
Explore the profile of Bjorn Fischler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teng J, Fischler B, Bohlin K, Reilly M, Tiblad E
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685506
We read with interest the recently published article in the , by Drozdowska-Szymczak et al [...].
2.
Swartling L, Engman M, Eriksen J, Fischler B, Friman V, Hobell H, et al.
Infect Dis (Lond)
. 2024 Aug;
56(10):907-917.
PMID: 39185773
Cytomegalovirus (CMV) infection, which mostly causes a subclinical infection early in life, has important clinical consequences in certain patient groups. CMV is the most common congenital infection and can cause...
3.
Considerable differences in management of cytomegalovirus infection in patients with biliary atresia
Liliemark U, Psaros Einberg A, Svensson J, Fischler B
JPGN Rep
. 2024 Aug;
5(3):303-308.
PMID: 39149178
Objectives: Patients with biliary atresia (BA) and ongoing cytomegalovirus (CMV) infection may have poorer outcomes after Kasai portoenterostomy than uninfected patients. Still, there is no consensus on the usefulness of...
4.
Vajro P, Mandato C, Fischler B
Virulence
. 2024 Feb;
15(1):2318582.
PMID: 38388366
No abstract available.
5.
Vajro P, Mandato C, Fischler B
J Infect
. 2024 Feb;
88(3):106127.
PMID: 38382858
No abstract available.
6.
Indolfi G, Gonzalez-Peralta R, Jonas M, Sayed M, Fischler B, Sokal E, et al.
J Pediatr Gastroenterol Nutr
. 2024 Feb;
78(4):957-972.
PMID: 38369891
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide, with more than three million viraemic adolescents and children. Treatment of adults with HCV infection and...
7.
Fischler B, Liliemark U, Psaros Einberg A, Svensson J
Hepatol Commun
. 2024 Jan;
8(2).
PMID: 38251901
No abstract available.
8.
Hansen B, Vandriel S, Vig P, Garner W, Mogul D, Loomes K, et al.
Hepatology
. 2023 Dec;
79(6):1279-1292.
PMID: 38146932
Background And Aims: Alagille syndrome (ALGS) is characterized by chronic cholestasis with associated pruritus and extrahepatic anomalies. Maralixibat, an ileal bile acid transporter inhibitor, is an approved pharmacologic therapy for...
9.
Gardin A, Ruiz M, Beime J, Cananzi M, Rathert M, Rohmer B, et al.
Orphanet J Rare Dis
. 2023 Dec;
18(1):383.
PMID: 38062451
Background: Oral cholic acid therapy is an effective therapy in children with primary bile acid synthesis deficiencies. Most reported patients with this treatment have 3β-hydroxy-Δ-C-steroid oxidoreductase deficiency. The aim of...
10.
Fischler B, Mandato C, Vajro P
Acta Paediatr
. 2023 Oct;
113(1):15-18.
PMID: 37818991
No abstract available.